Lexicon Pharmaceuticals | LXRX - Action





Action Changement Date
Abbott USD 6.49B 220M 2025-12
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Akebia Therapeutics USD 15.61M 3.03M 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
AstraZeneca USD 6.59B 126M 2025-09
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Coherus Biosciences USD 3.17M 1.12M 2025-12
Eli Lilly USD 13.74B 1.56B 2025-12
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Illumina USD 564M 26M 2025-12
Insmed USD 132.07M 11.1M 2025-12
J&J USD 14.19B 45M 2025-12
Lexicon Pharmaceuticals USD 168K 33K 2025-06
MacroGenics USD 7.91M 840K 2025-12
MannKind USD 35.31M 8.34M 2025-12
Merck USD 6.44B 157M 2025-09
Moderna USD 332M 92M 2025-09
Novartis USD 6.42B 114M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Thermo Fisher Scientific USD 5.43B 320M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
United Therapeutics USD 183.1M 6.6M 2025-12
Vanda Pharmaceuticals USD 1.85M 190K 2025-12